Kusumika Saha

Kusumika Saha

Auto-generated profile, based on publicly available information

Kusumika Saha

Department of Medicine, Brigham and Women’s Hospital, Boston, MA (K.S., M.L.B., W.H.B., A.K.C., M.H., R.A.V., D.Q., A.W., E.P., C.A.M.).

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 August 2026 in Circulation Research
Verified
Journal Article
Open access
QGQianyun Ge
Qianyun Ge
KSKusumika Saha
Kusumika Saha
MBMicah L. Burch
Micah L. Burch
WBWillow H. Battista
Willow H. Battista
AKAshmita Kc
Ashmita Kc
WZWandi Zhu
Wandi Zhu
BACKGROUND: Variants in PRKAG2 cause hypertrophic cardiomyopathy and conduction disturbances. Although prior studies associated PRKAG2 -related hypertrophy with increased glycogen storage, many hypertrophic cardiomyopathy phenotypes remain unexplained. We aimed to uncover how PRKAG2 variants induce myocyte hypertrophy and electrical changes during early cardiac development. METHODS: We generated transgenic zebrafish expressing wild-type or pathogenic variant Prkag2 under a myocardium-specific promoter, Tg( cmcl2 : Prkag2 WT ) (Tg WT ) and Tg( cmcl2 : Prkag2 R299Q ) (Tg R299Q ), respectively, and examined cardiac electrophysiology, contractile function, and cytoarchitecture during cardiogenesis and in adult hearts. RESULTS: Tg R299Q fish showed hypertrophic cardiomyocytes and progressive contractile abnormalities, recapitulating human hypertrophic cardiomyopathy phenotypes. Cardiomyocyte glycogen was elevated in adult but not embryonic hearts. Despite the absence of glycogen accumulation at 6 days post-fertilization, Tg R299Q hearts showed electrical abnormalities, including reduced conduction velocity and prolonged action potential and Ca 2+ transient durations, compared to Tg WT and wild-type (Tübingen/AB [TuAB]). We observed decreased AMPK (AMP-activated protein kinase) phosphorylation in the Tg R299Q hearts. However, AMPK activation did not rescue the electrophysiological abnormalities in Tg R299Q . Proximity ligation assays and coimmunoprecipitation identified a physical interaction between AMPKγ2 and myosin, enhanced by the R299Q variant and accompanied by increased AMPKγ2 localization to the myofilament. NCX (Na + /Ca 2+ exchanger) inhibition increased Ca 2+ duration and diastolic Ca 2+ in Tg WT but not Tg R299Q hearts, indicating reduced free cytosolic Ca 2+ for NCX-mediated extrusion in Tg R299Q . These findings suggest that enhanced AMPKγ2-myosin interaction may promote myofilament Ca 2 + retention, thereby prolonging Ca 2 + transient duration and action potential duration in the mutant. Notably, the myosin inhibitor mavacamten reduced AMPKγ2-myosin interaction in Tg R299Q hearts, and both mavacamten and vmhcl knockdown rescued the early electrophysiological abnormalities. CONCLUSIONS: The PRKAG2 variant altered cardiac excitability, contractility, and Ca 2+ handling during cardiogenesis, independent of glycogen accumulation. Enhanced interactions between AMPKγ2 and myosin contributed to these early changes. Our study revealed a novel link between cellular energy sensing and contractile machinery, with therapeutic potential for modulating contractile function in cardiomyopathies.